MKI67 and primary biliary cholangitis: The phenotypes of the two NK cell subsets were stable across all treatment groups and times, indicating that the greater number of circulating CD16+ NK after PBC treatment was unlikely to have been due to an alteration in phenotype or an increase in cell division (marked by expression of the Ki67 antigen).